TY - JOUR T1 - Amplicon contamination in labs masquerades as COVID19 in surveillance tests JF - medRxiv DO - 10.1101/2020.12.08.20244525 SP - 2020.12.08.20244525 AU - Dan Davidi AU - Susan Fitzgerald AU - Hannah L. Glaspell AU - Samantha Jalbert AU - Stylianos Maheras AU - Stephanie E. Mattoon AU - Vanessa M. Britto AU - Davidson H. Hamer AU - Giang T. Nguyen AU - Judy Platt AU - Cecilia W. Stuopis AU - Joshua E. Turse AU - Michael Springer Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/12/15/2020.12.08.20244525.abstract N2 - A cohort of laboratorians with positive SARS-CoV2 test results were uncovered during asymptomatic COVID-19 screening programs at six universities. Follow-up PCR and antibody tests showed that most of these cases were not true COVID-19 infection but instead arose from reverse-transcribed and amplified viral sequences (amplicons) that are generated during research. Environmental testing showed widespread contamination of amplicons in lab spaces including notebooks, keyboards, glasses, and doorknobs. Minimizing instances of amplicon contamination and developing protocols for handling suspected cases are critical to propel research efforts and to avoid diverting university and healthcare resources from patients with COVID-19. Removal of these individuals from the standard testing protocol, per CDC guidelines for positive cases, risks the spread of true infection. We discuss potential prevention and mitigation strategies.Competing Interest StatementThe authors have declared no competing interest.Funding Statementno external funding was receivedAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Improving Point-of-Care Diagnostics for COVID-19 IRB20-0581 The Institutional Review Board (IRB) of the Harvard Faculty of Medicine approved this Initial StudyAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.Yesall data presented in this paper is available on submission as a supporting excel file ER -